Hem » Publications » Archive » 2021
-
Norlin JM, Kellerborg L, Odin P
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson’s Disease: A Swedish Register-Based Study in 1823 Observations
Pharmacoeconomics, 2021 Oct;39(10):1141-1149
DOI: 10.1007/s40273-021-01056-z
-
Arthursson V, Rosén R, Norlin JM, Gralén K, Toth E, Syk I, Thorlacius H, Rönnow CF
Cost Comparisons Of Endoscopic And Surgical Resection Of T1 Rectal Cancer
Endoscopy 2021; 53(S 01): S253-S254
DOI: 10.1055/s-0041-1724964
-
Hofmarcher T, Keel G, Lindgren P
Cancer care and access to cancer drugs in Asia-Pacific – Main report
IHE Report 2021:3, IHE: Lund, Sweden
-
Hofmarcher T, Keel G, Lindgren P
Pricing policies for off-patent drugs in Asia-Pacific
IHE Report 2021:3g, IHE: Lund, Sweden
-
Hofmarcher T, Keel G, Lindgren P
Health spending on cancer drugs and unmet patient needs in Asia-Pacific
IHE Report 2021:3f, IHE: Lund, Sweden
-
Hofmarcher T, Keel G, Lindgren P
Patient access to innovative cancer drugs in Asia-Pacific
IHE Report 2021:3e, IHE: Lund, Sweden
-
Olsson P, Skröder C, Ahlbeck L, Hjalte F, Welin K-O, Westin U, Andersson M, Ahlström-Emanuelsson C, Cardell L-O
HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study
Allergy, Asthma & Clinical Immunology 17, 55 (2021)
DOI: https://doi.org/10.1186/s13223-021-00560-3
-
Hofmarcher T, Keel G, Lindgren P
Health spending on cancer in Asia-Pacific
IHE Report 2021:3d, IHE: Lund, Sweden
-
Hofmarcher T, Keel G, Lindgren P
The burden of cancer in Asia-Pacific
IHE Report 2021:3c, IHE: Lund, Sweden
-
Hofmarcher T, Keel G, Lindgren P
Cancer care and access to cancer drugs in Asia-Pacific – Executive summary
IHE Report 2021:3b, IHE: Lund, Sweden
Back »Next »